EGETIS THERAPEUTICS ABEGETIS THERAPEUTICS ABEGETIS THERAPEUTICS AB

EGETIS THERAPEUTICS AB

No trades
See on Supercharts

Price target

13.980.000.00%
The 5 analysts offering 1 year price forecasts for EGTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to EGTX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


EGTX EPS for the last quarter is −0.31 SEK despite the estimation of −0.26 SEK. In the next quarter EPS is expected to reach −0.24 SEK. Track more of EGETIS THERAPEUTICS AB financials and stay on top of what is up with the company.
In the next quarter EGETIS THERAPEUTICS AB revenue is expected to reach ‪12.70 M‬ SEK. Check out EGETIS THERAPEUTICS AB revenue and earnings and make informed decisions.
According to analysts, EGTX price target is 13.98 SEK with a max estimate of 16.90 SEK and a min estimate of 11.00 SEK. Check if this forecast comes true in a year, meanwhile watch EGETIS THERAPEUTICS AB stock price chart and keep track of the current situation with EGTX news and stock market news.